Experience

IN8bio

• United States
• Biotechnology Research
• 1 - 100 Employee

• Chairman Of The Board Of Directors

  • Sep 2020 - 3 years 4 months

  New York, New York, United States Allogeneic, autologous and genetically modified gamma-delta T cell therapies for the treatment of cancers. Nasdaq: INAB



UTILITY therapeutics

• United Kingdom
• Biotechnology Research
• 1 - 100 Employee

• Chairman Of The Board Of Directors

  • Mar 2020 - 3 years 10 months

  London, England, United Kingdom Bringing European-approved antibiotics, pivmecillinam and mecillinam, to the United States for the treatment of urinary tract infections.



bit.bio

• United Kingdom
• Biotechnology Research
• 100 - 200 Employee

• Board of Directors and Chair of Audit, Compensation and Finance Committees

  • Aug 2021 - 2 years 5 months

  Cambridge, England, United Kingdom Scalable technology platform capable of producing consistent batches of every human cell.



NexImmune, Inc.

• United States
• Biotechnology Research
• 1 - 100 Employee

• Board of Directors and Chair of Audit Committee

  • Feb 2017 - 6 years 11 months

  Gaithersburg, Maryland, United States Directing T cell function for targeted immunity. Nasdaq: NEXI • Chairman of the Board of Directors, December 2017 - November 2019 • Director and Audit Committee Chair, February 2017 - Present



Helene Fuld College of Nursing

• United States
• Higher Education
• 1 - 100 Employee

• Board of Trustees and Treasurer

  • Jun 2014 - 9 years 7 months

  New York, New York, United States A private, not-for-profit institution at the forefront of nursing education.



Biolojic Design, Ltd.

• Biotechnology Research
• 1 - 100 Employee

• Senior Advisor

  • Jul 2021 - 2 years 6 months

  Reẖovot, Central, Israel Reimagining therapeutic antibodies using Artificial Intelligence



DC Brau Brewing LLC

• Food and Beverage Services
• 1 - 100 Employee

• Founding Investor and Management Committee Member

  • Aug 2010 - 13 years 5 months

  Washington, District of Columbia, United States Washington, D.C.'s first packaging brewery since 1956. • Management Committee Member, May 2017 - Present



Envisagenics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Board of Directors

  • Mar 2020 - Feb 2023

  New York, New York, United States Using Artificial Intelligence to deliver therapies for RNA splicing diseases. • Board of Directors, September 2021 - February 2023 • Business Advisory Board, March 2020 - February 2023



Roivant Sciences

• United States
• Biotechnology
• 100 - 200 Employee

• Founding Leadership Team and Founding Investor

  • May 2014 - Aug 2019

  New York, New York, United States Rapidly developing innovative medicines through a novel form of industrial organization in R&D. Nasdaq: ROIV • Founding Leadership Team and Founding Investor, May 2014 • Senior Vice President, Finance & Operations and Secretary, May 2014 - June 2016 • Senior Vice President, Corporate Development, July 2016 - December 2018 • Senior Advisor, January 2019 - August 2019



SomPharmaceuticals SA

• Board of Directors

  • Aug 2012 - May 2016

  Epalinges, Vaud, Switzerland Somatostatin analogues for the treatment of Acromegaly and neuroendocrine tumors. SomPharmaceuticals was acquired by Amryt Pharma plc (Nasdaq: AMYT).



Axovant Sciences

• Founding Leadership Team and Chief Financial Officer

  • Oct 2014 - Aug 2015

  New York, New York, United States Gene therapies for the treatment of neurological and neuromuscular diseases. Axovant is a subsidiary of Roivant Sciences. • Founding Leadership Team, October 2014 • Senior Vice President, Finance & Operations, October 2014 - March 2015 • Chief Financial Officer, March 2015 - August 2015 • Principal Financial and Accounting Officer of Axovant Sciences Ltd., March 2015 - August 2015



The Trout Group

• United States
• Biotechnology Research
• 1 - 100 Employee

• Managing Director

  • Nov 2009 - Apr 2014

  New York, New York, United States Strategic advisory and investor relations firm servicing the life sciences industry.



Zelos Therapeutics

• Biotechnology Research
• 1 - 100 Employee

• Chief Financial Officer & Treasurer

  • Jun 2008 - Nov 2009

  Greater Philadelphia Focused on the development of therapies for severe osteoporosis.



Pharmasset, Inc.

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Founding Leadership Team and Vice President

  • Jul 1999 - May 2008

  Atlanta, Georgia and Princeton, New Jersey, United States Discovery and development of novel therapeutics to treat viral infections. Pharmasset (Nasdaq: VRUS) was acquired by Gilead (Nasdaq: GILD) for $11 billion. • Vice President, Business Development & General Manager, 1999 – 2004 • Vice President, Finance & Administration, 2004 – 2005 • Vice President, Finance & Investor Relations, 2005 – 2006 • Vice President, Investor Relations & Corporate Communications, 2007 – 2008



Georgia Bio

• United States
• Biotechnology
• 1 - 100 Employee

• Board of Directors and Membership Chair

  • 2001 - 2005

  Atlanta, Georgia, United States Georgia Bio is the state affiliate of the Washington, D.C.-based Biotechnology Industry Organization (BIO).



Deloitte

• Business Consulting and Services
• 700 & Above Employee

• Consultant

  • 1995 - 1997

  Atlanta, Georgia, United States



Booz Allen Hamilton

• United States
• IT Services and IT Consulting
• 700 & Above Employee

• Senior Consultant

  • 1994 - 1995

  Atlanta, Georgia, United States



Bank of America

• United States
• Banking
• 700 & Above Employee

• Management Associates Program, Project Analyst

  • 1992 - 1993

  Atlanta, Georgia, United States